Who is eligible? 

Eligible participants are English or Spanish speaking adults (or parents/guardians of children) who have received unexpected or suprising health findings from genomic testing.  National Institutes of Health (NIH) personnel will help applicants quickly determine if they are eligible. 

Specifically, participants will have received secondary findings of pathogenic genomic variants in genes recommended by the American College of Medical Genetics and Genomics as a result of direct-to-consumer (e.g., 23andMe or Ancestry.com), clinical, or research-based genomic sequencing. 

• Eligibility Example #1: Mary and Jennifer both have genomic testing and are found to have a pathogenic mutation in the MSH6 gene, which causes colon and uterine cancer (Lynch syndrome). Mary had genomic testing because her father and uncle were both recently diagnosed with colon cancer. Jennifer had genomic testing as part of her son’s autism diagnostic workup (or through Ancestry.com). Even though they both have a mutation in the same gene, Jennifer is eligible for GSRP because she was not being tested to determine her risk for this disease.  Mary is not eligible.

​

• Eligibility Example #2: Dan completes a 23andMe genomic testing kit to find out about what part of the world his family is from. 23andMe’s DNA analysis discovers that Dan has a mutation in the MSH2 gene which causes Lynch Syndrome and puts Dan at a higher risk of developing colon cancer. Dan is eligible for GSRP.